Table 5.
Univariable analyses | Multivariable analyses | |||||
OR | 95% CI | P value | aOR | 95% CI | P value | |
Anti-TNF-α monotherapy | 0.84 | 0.46 to 1.51 | 0.55 | 0.84 | 0.44 to 1.26 | 0.61 |
Thiopurine monotherapy | 1.26 | 0.82 to 1.94 | 0.29 | 1.16 | 0.71 to 1.88 | 0.55 |
Anti-TNF-α and thiopurine | 1.54 | 0.76 to 3.12 | 0.23 | 1.43 | 0.66 to 3.12 | 0.37 |
Systemic corticosteroids | 2.81 | 1.81 to 4.35 | <0.01 | 2.62 | 1.56 to 4.38 | <0.01 |
Disease activity | 1.61 | 1.06 to 2.46 | 0.02 | 1.06 | 0.61 to 1.89 | 1.83 |
IBD type (CD or UC/IBDU) | 0.81 | 0.57 to 1.17 | 0.26 | |||
Maternal age | 0.97 | 0.93 to 1.02 | 0.28 | |||
Smoking during pregnancy | 0.98 | 0.41 to 2.35 | 0.96 | |||
Obstetric complications | 1.35 | 1.22 to 1.49 | <0.01 | 4.07 | 2.54 to 6.54 | <0.01 |
Endoscopy during pregnancy | 1.94 | 1.08 to 3.47 | 0.02 | 1.17 | 0.57 to 2.38 | 0.83 |
aOR, adjusted odds ratio; CD, Crohn’s disease; IBD, inflammatory bowel disease; IBDU, inflammatory bowel disease unclassified; TNF, tumour necrosis factor; UC, ulcerative colitis.